Evidence map›Paper›PMID 28660210›Full record

ArticleBioMed research international2017

Kinetics of Tyrosinase Inhibitory Activity Using

Yung-Sheng Lin, Hui-Ju Chen, Jung-Ping Huang, Pei-Chi Lee, Ching-Ru Tsai, Tzu-Fang Hsu, Wen-Ying Huang

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 52 citations in OpenAlex.

  1. Antibiotics (Basel, Switzerland) · 2024
    Review
  2. Review
  3. Review
  4. Review
  5. Shoot Cultures ofMolecules (Basel, Switzerland) · 2023
    Article
  6. Pharmaceutics · 2023
    Review
  7. Valorization of grape (Frontiers in chemistry · 2023
    Review
  8. Microwave-AssistedAntioxidants (Basel, Switzerland) · 2022
    Article
  9. Review
  10. Review
  11. Functionality of Silk Cocoon (Materials (Basel, Switzerland) · 2021
    Article
  12. Article
  13. Article
  14. Selecting and Characterizing Tyrosinase Inhibitors fromJournal of analytical methods in chemistry · 2021
    Article
  15. Article
  16. New Insights into the Exploitation ofAntioxidants (Basel, Switzerland) · 2020
    Article
  17. Article
  18. A comprehensive review on tyrosinase inhibitors.Journal of enzyme inhibition and medicinal chemistry · 2019
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Yung-Sheng LinDepartment of Chemical Engineering, National United University, Miaoli, Taiwan.ORCID 0000-0002-9522-1812
Hui-Ju ChenDepartment of Food Science and Biotechnology, National Chung Hsing University, Taichung, Taiwan.ORCID 0000-0002-3171-5231
Jung-Ping HuangDepartment of Applied Cosmetology, Master Program of Cosmetic Science, Hung-Kuang University, Taichung, Taiwan.
Pei-Chi LeeDepartment of Applied Cosmetology, Master Program of Cosmetic Science, Hung-Kuang University, Taichung, Taiwan.
Ching-Ru TsaiDepartment of Applied Cosmetology, Master Program of Cosmetic Science, Hung-Kuang University, Taichung, Taiwan.
Tzu-Fang HsuDepartment of Applied Cosmetology, Master Program of Cosmetic Science, Hung-Kuang University, Taichung, Taiwan.
Wen-Ying HuangDepartment of Applied Cosmetology, Master Program of Cosmetic Science, Hung-Kuang University, Taichung, Taiwan.ORCID 0000-0001-9142-0542
Hungkuang University · TWNational Chung Hsing University · TWNational United University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural medical plant is considered as a good source of tyrosinase inhibitors. Red vine leaf extract (RVLE) can be applied to a wide variety of medical disciplines, such as treatments for chronic venous insufficiency over many decades. This study investigated the tyrosinase inhibitory activity of RVLE containing gallic acid, chlorogenic acid, epicatechin, rutin, and resveratrol which are effective for skin hyperpigmentation. The five components contents are 1.03, 0.2, 18.55, 6.45, and 0.48 mg/g for gallic acid, chlorogenic acid, epicatechin, rutin, and resveratrol. The kinetic study showed the tyrosinase inhibitory of RVLE via a competitive reaction mechanism. RVLE solution has an IC

Indexed as

AntioxidantsEnzyme InhibitorsHumansHyperpigmentationKineticsMonophenol MonooxygenasePlant ExtractsPlant LeavesSkinVitisAntioxidantsEnzyme InhibitorsMonophenol MonooxygenasePlant Extracts

Identifiers

PMID28660210
PMCPMC5474274
OpenAlexW2620960211

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.